E.coli-derived human ACSL5 recombinant protein (Position: Y108-D683). Human ACSL5 shares 80.7% and 80.2% amino acid (aa) sequence identity with mouse and rat ACSL5, respectively.
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Reinheit:
Immunogen affinity purified.
Formulierung:
Liquid
Target-Kategorie:
Long-chain-fatty-acid--CoA ligase 5
Application Verdünnung:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten